| Literature DB >> 34099494 |
Fei Yue1, Weiyu Jiang1, Amy T Ku1, Adelaide I J Young1, Weijie Zhang1, Eric P Souto1, Yankun Gao2, Zihan Yu2, Yi Wang2, Chad J Creighton3,4, Chandandeep Nagi1,5, Tao Wang4, Susan G Hilsenbeck1,4, Xin-Hua Feng6,7,8, Shixia Huang4,6, Cristian Coarfa3,6,9, Xiang H-F Zhang1,4,6,10, Qingyun Liu11, Xia Lin7, Yi Li12,4,6,13.
Abstract
Leucine-rich repeat-containing G protein-coupled receptors 4, 5, and 6 (LGR4/5/6) play critical roles in development and cancer. The widely accepted mechanism is that these proteins, together with their R-spondin ligands, stabilize Wnt receptors, thus potentiating Wnt signaling. Here we show that LGR4 enhanced breast cancer cell metastasis even when Wnt signaling was deactivated pharmacologically or genetically. Furthermore, LGR4 mutants that cannot potentiate Wnt signaling nevertheless promoted breast cancer cell migration and invasion in vitro and breast cancer metastasis in vivo. Multiomic screening identified EGFR as a crucial mediator of LGR4 activity in cancer progression. Mechanistically, LGR4 interacted with EGFR and blocked EGFR ubiquitination and degradation, resulting in persistent EGFR activation. Together, these data uncover a Wnt-independent LGR4-EGFR signaling axis with broad implications for cancer progression and targeted therapy. SIGNIFICANCE: This work demonstrates a Wnt-independent mechanism by which LGR4 promotes cancer metastasis.See related commentary by Stevens and Williams, p. 4397. ©2021 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2021 PMID: 34099494 PMCID: PMC8416783 DOI: 10.1158/0008-5472.CAN-21-1112
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 13.312